The upregulation of TRPV4/Piezo1 transcription by TGFβ2 predicts exaggerated responsiveness to mechanical loading, as reported for chemotherapy (108), neuropathic pain (109, 110), cancer (111), and diabetic neuropathy (112). Here, TGFB2 is linked to cancer.